291 related articles for article (PubMed ID: 25953156)
21. Double-edged swords as cancer therapeutics: novel, orally active, small molecules simultaneously inhibit p53-MDM2 interaction and the NF-κB pathway.
Zhuang C; Miao Z; Wu Y; Guo Z; Li J; Yao J; Xing C; Sheng C; Zhang W
J Med Chem; 2014 Feb; 57(3):567-77. PubMed ID: 24428757
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and cytotoxic activities of novel hybrid compounds between dihydrobenzofuran and imidazole.
Chen W; Yang XD; Li Y; Yang LJ; Wang XQ; Zhang GL; Zhang HB
Org Biomol Chem; 2011 Jun; 9(11):4250-5. PubMed ID: 21505704
[TBL] [Abstract][Full Text] [Related]
23. Fluorinated Benzofuran and Dihydrobenzofuran as Anti-Inflammatory and Potential Anticancer Agents.
Ayoub AJ; El-Achkar GA; Ghayad SE; Hariss L; Haidar RH; Antar LM; Mallah ZI; Badran B; Grée R; Hachem A; Hamade E; Habib A
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373544
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of chroman-2-carboxylic acid N-(substituted)phenylamides and their inhibitory effect on nuclear factor-kappaB (NF-kappaB) activation.
Kwak JH; Won SW; Kim TJ; Roh E; Kang HY; Lee HW; Jung JK; Hwang BY; Kim Y; Cho J; Lee H
Arch Pharm Res; 2008 Feb; 31(2):133-41. PubMed ID: 18365680
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of lantadene analogs with marked in vitro inhibition of lung adenocarcinoma and TNF-α induced nuclear factor-kappa B (NF-κB) activation.
Monika ; Sharma A; Suthar SK; Aggarwal V; Lee HB; Sharma M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3814-8. PubMed ID: 25027934
[TBL] [Abstract][Full Text] [Related]
26. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and biological evaluation of novel 1-oxo-1,2,3,4-tetrahydropyrazino[1,2-a]indole-3-carboxamide analogs in MCF-7 and MDA-MB-468 breast cancer cell lines.
Kim YJ; Pyo JS; Jung YS; Kwak JH
Bioorg Med Chem Lett; 2017 Feb; 27(3):607-611. PubMed ID: 27993518
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological activities of 2-amino-thiazole-5-carboxylic acid phenylamide derivatives.
Liu W; Zhou J; Qi F; Bensdorf K; Li Z; Zhang H; Qian H; Huang W; Cai X; Cao P; Wellner A; Gust R
Arch Pharm (Weinheim); 2011 Jul; 344(7):451-8. PubMed ID: 21598297
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and anticancer activity of novel hybrid compounds between benzofuran and N-aryl piperazine.
Mao ZW; Zheng X; Lin YP; Hu CY; Wang XL; Wan CP; Rao GX
Bioorg Med Chem Lett; 2016 Aug; 26(15):3421-4. PubMed ID: 27371110
[TBL] [Abstract][Full Text] [Related]
30. Bis(4-hydroxy-2H-chromen-2-one): synthesis and effects on leukemic cell lines proliferation and NF-κB regulation.
Talhi O; Schnekenburger M; Panning J; Pinto DG; Fernandes JA; Almeida Paz FA; Jacob C; Diederich M; Silva AM
Bioorg Med Chem; 2014 Jun; 22(11):3008-15. PubMed ID: 24775915
[TBL] [Abstract][Full Text] [Related]
31. Exploration of 2-benzylbenzimidazole scaffold as novel inhibitor of NF-κB.
Boggu P; Venkateswararao E; Manickam M; Kwak D; Kim Y; Jung SH
Bioorg Med Chem; 2016 Apr; 24(8):1872-8. PubMed ID: 26976506
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents.
Yang XH; Xiang L; Li X; Zhao TT; Zhang H; Zhou WP; Wang XM; Gong HB; Zhu HL
Bioorg Med Chem; 2012 May; 20(9):2789-95. PubMed ID: 22503364
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of coumaperine derivatives: Their NF-κB inhibitory effect, inhibition of cell migration and their cytotoxic activity.
Nandakumar N; Muthuraman S; Gopinath P; Nithya P; Gopas J; Kumar RS
Eur J Med Chem; 2017 Jan; 125():1076-1087. PubMed ID: 27810594
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of novel 1,2,3-triazole derivatives of coronopilin as anti-cancer compounds.
Khazir J; Hyder I; Gayatri JL; Prasad Yandrati L; Nalla N; Chasoo G; Mahajan A; Saxena AK; Alam MS; Qazi GN; Sampath Kumar HM
Eur J Med Chem; 2014 Jul; 82():255-62. PubMed ID: 24910974
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and cytotoxicity evaluation of biaryl-based chalcones and their potential in TNFα-induced nuclear factor-κB activation inhibition.
Zuo Y; Yu Y; Wang S; Shao W; Zhou B; Lin L; Luo Z; Huang R; Du J; Bu X
Eur J Med Chem; 2012 Apr; 50():393-404. PubMed ID: 22386368
[TBL] [Abstract][Full Text] [Related]
36. Novel 1-(7-ethoxy-1-benzofuran-2-yl) substituted chalcone derivatives: Synthesis, characterization and anticancer activity.
Coskun D; Erkisa M; Ulukaya E; Coskun MF; Ari F
Eur J Med Chem; 2017 Aug; 136():212-222. PubMed ID: 28494257
[TBL] [Abstract][Full Text] [Related]
37. Naturally occurring and synthetic inhibitors of NF-kappaB functions.
Umezawa K; Ariga A; Matsumoto N
Anticancer Drug Des; 2000 Aug; 15(4):239-44. PubMed ID: 11200499
[TBL] [Abstract][Full Text] [Related]
38. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationships of 6-hydroxy-7-methoxychroman-2-carboxylic acid N-(substituted)phenylamides as inhibitors of nuclear factor-kappaB activation.
Kwak JH; Kim BH; Jung JK; Kim Y; Cho J; Lee H
Arch Pharm Res; 2007 Oct; 30(10):1210-5. PubMed ID: 18038899
[TBL] [Abstract][Full Text] [Related]
40. Discovery of antitumor ursolic acid long-chain diamine derivatives as potent inhibitors of NF-κB.
Jiang W; Huang RZ; Zhang J; Guo T; Zhang MT; Huang XC; Zhang B; Liao ZX; Sun J; Wang HS
Bioorg Chem; 2018 Sep; 79():265-276. PubMed ID: 29778798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
